tertatolol

This page covers all tertatolol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 1A, Beta-3 adrenergic receptor, 5-hydroxytryptamine receptor 1A.

Targets

5-hydroxytryptamine receptor 1A, Beta-3 adrenergic receptor, 5-hydroxytryptamine receptor 1A

Phase 2 pipeline (1)

• Dl-Tertatolol · Metabolic
  Tertatolol works by binding to and activating the beta-3 adrenergic receptor, which is involved in regulating various physiological processes.

Patent intelligence

• tertatolol patent landscape — aggregated cliff calendar, attackable patents, originator estates